Effective: April 2026 (Pilot)
These terms and conditions apply to the use of Gentu Scribe and are incorporated into and form part of the Master Services Agreement (MSA) between your practice and Magentus Practice Management Pty Ltd ACN 086 370 130 (Magentus, we, us or our). These terms also supplement and should be read together with the general commitments described in the Magentus Data and AI Trust Centre.
Your practice has agreed to participate in the pilot release of Gentu Scribe – an AI-assisted consultation documentation service that records, transcribes, and converts patient-practitioner consultations into structured clinical notes, correspondence, and other documentation within Gentu.
1. What Gentu Scribe Does
Gentu Scribe uses AI including speech-to-text and natural language models to:
Record and transcribe consultation audio
Generate structured clinical notes, consultation summaries, and correspondence
Support the practitioner in documenting and managing the patient’s care arising from that consultation
2. Data Processed
Gentu Scribe processes personal information, health information, and sensitive information of patients and practitioners (Relevant Information). This includes personal identifiers (e.g. name, date of birth), details of physical or mental health, symptoms, diagnoses, treatments, and other information arising from the consultation.
3. How Data Is Handled
Consultation audio is encrypted (AES-256 at rest, TLS 1.2+ in transit) and transmitted to the following AI service providers for processing:
Provider | Services |
|---|---|
AssemblyAI | Speech-to-text transcription |
Large language models (LLMs) |
Not all providers are used in every feature. The specific providers used for each capability may change over time as we evaluate and optimise our AI infrastructure. Refer to our Trust Centre for the full list of service providers, which may be updated as new AI-enabled capabilities become available in Gentu in the future. We use our best endeavours to ensure our partners / service providers involved in processing your data (including transcription and LLM providers) are committed to not using your data for LLM training, LLM improvement or any purpose beyond providing the specific service requested.
Audio recordings are retained securely in Australian data centres for 30 days, then automatically destroyed. Processing may briefly occur in secure overseas facilities operated by our vetted AI service providers. Clinical notes and other outputs generated by Gentu Scribe are saved directly into the patient’s medical record in Gentu and stored exclusively in Australia.
No data processed by Gentu Scribe is used to train the large language models used in our products. This is a written commitment from the AI service providers listed above.
4. Patient Consent
Before using Gentu Scribe during a patient consultation, the practitioner must obtain the patient’s consent. Patient consent for audio recording consultations is legally required in most Australian states/territories, and is strongly recommended as best practice.
The practice is responsible for obtaining, recording, and managing patient consent. We recommend obtaining consent as part of new-patient onboarding (typically at the first visit). Alternatively, if written patient consent is challenging, verbal consent should be sought and documented in the clinical note. We have provided a suggested form of written patient consent for your patients to sign, plus suggested patient consent language for verbal consent, in the Gentu Scribe information pack we emailed to your practice. You can also find this information on our Scribe webpage.
You confirm that your practice has obtained each patient’s consent before using Gentu Scribe, and that such consent was obtained in accordance with applicable Australian privacy laws.
5. AI Service Providers as Authorised Users
By agreeing to these terms and using Gentu Scribe, the practice authorises Magentus and the AI service providers listed above to access and process consultation audio and Relevant Information as described in these terms and in the Trust Centre.
6. Pilot Release — Limitations and Disclaimers
During the pilot release of Gentu Scribe:
Gentu Scribe has not been publicly released and is provided “as is.”
The practice uses Gentu Scribe at its own risk.
Outputs from Gentu Scribe (Scribe Outputs) — including clinical notes, summaries, and correspondence — may contain errors, omissions, or inaccuracies.
It is the practitioner’s responsibility to review and confirm the accuracy and completeness of all Scribe Outputs before they are relied upon, acted on, or incorporated into patient records — now and into the future.
Gentu Scribe and the Scribe Outputs do not constitute medical, commercial, or any other advice from Magentus and must not be used as a substitute for the examination of the patient’s records and the exercise of clinical judgement.
To the maximum extent permitted by law, Magentus is not liable for any damage, claim, or loss (including any indirect or consequential loss) incurred by the practice in connection with or arising from the use of or reliance on Gentu Scribe or the Scribe Outputs.
Magentus may withdraw the pilot version of Gentu Scribe at any time and for any reason, with or without notice.
7. Relationship with other terms
Copyright Magentus Practice Management Pty Ltd | Data and AI Trust Centre | [email protected]
